United States · FDA National Drug Code directory
Lithium Carbonate ER
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42291-496_485f83f8-8405-eae8-e063-6294a90a3c33
- Product NDC
- 42291-496
- Form
- TABLET
- Composition / generic term
- Lithium Carbonate
- Labeler
- AvKARE
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220225
- Source listing expiry
- 20271231
Source-listed ingredients
- LITHIUM CARBONATE — 450 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (42291-496-01) · 42291-496-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →